{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"selank-postherpetic","title":"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers","body":"## What's breaking down\n\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months or years in some people. Chronic pain often triggers secondary layers: elevated stress chemistry, disrupted sleep, and heightened anxiety that amplifies perceived pain intensity. If anxiety and non-restorative arousal form part of your experience, that neurochemistry layer becomes a separate target for repair pathways.\n\n## Why Selank might help you\n\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. In postherpetic neuralgia the constant pain input keeps the nervous system on high alert.\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\n3. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nRussian human trials examined Selank in generalized anxiety disorder and neurasthenia. Patients showed reductions in anxiety scores comparable to certain benzodiazepines yet without sedation or cognitive dulling. If your postherpetic pain feeds ongoing worry or tension that prevents rest, the studied effect on GABA-related gene expression and enkephalin stability offers a distinct angle focused on restoring balance rather than suppressing symptoms.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- Selank → anxiety / neurochemistry\n\nSelank addresses the neurochemical amplification layer that often accompanies chronic nerve pain. Other compounds would map to separate degeneration points such as direct nerve repair or inflammation if included.\n\n## What the evidence actually shows\n\nHuman data exists only for anxiety indications. One 2008 trial with 62 patients compared Selank to medazepam and reported similar anxiolytic effects plus additional anti-asthenic benefits. Another 2015 study of 70 patients noted improved outcomes when Selank was added to benzodiazepines with fewer side effects. These trials used psychometric scales such as Hamilton Anxiety Rating. No published human trials test Selank specifically in postherpetic neuralgia. Animal and in-vitro work shows changes in GABA receptor gene expression and inflammation-related genes, yet these remain preclinical. Anecdotal reports on forums describe subjective calm without sedation, but these lack controlled measurement.\n\n## What scientists say\n\nPublished papers describe Selank as producing anxiolytic activity comparable to classical benzodiazepines via possible allosteric modulation of GABA systems and effects on enkephalin degradation. Russian researchers note rapid or gradual response patterns in generalized anxiety disorder cohorts. Western reviews highlight small sample sizes and limited long-term data. No statements link the peptide directly to neuropathic pain syndromes such as postherpetic neuralgia.\n\n## What people say on Reddit\n\nDiscussions mention Selank in contexts of general anxiety or benzo tapering. Users report reduced mental tension and clearer thinking. No threads specifically tie Selank to postherpetic neuralgia pain scores. Reports remain subjective and unverified.\n\n## What people say on X\n\nPosts describe Selank as providing calm without fog. Some users note improved focus during stress. No verified posts reference postherpetic neuralgia or shingles-related pain.\n\n## What we do not know\n\nDirect effects on nerve pain pathways in postherpetic neuralgia remain unstudied in humans. Long-term safety beyond short Russian trials is unknown. Optimal use alongside standard neuropathic pain treatments lacks comparative data. Individual response variability and duration of benefit are not quantified outside anxiety populations.\n\n## Safety and limits\n\nReported side effects in available human studies appear minimal. Russian approval exists for generalized anxiety disorder. The compound is not FDA-evaluated or approved for any use in the United States. Evidence for any postherpetic application rests entirely on mechanistic overlap with anxiety pathways rather than condition-specific trials.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/selank-postherpetic/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No published human trials test Selank in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s0","s9"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2008 trial with 62 patients found Selank produced anxiolytic effects comparable to medazepam in generalized anxiety disorder and neurasthenia.","section":"What the evidence actually shows","tier":"human","source_ids":["s9","s15"],"source_status":"sourced","why_material":"Provides the primary human efficacy data for the peptide's studied indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Selank alters expression of genes involved in neurotransmission including GABA-related pathways in rat frontal cortex studies.","section":"What scientists say","tier":"preclinical","source_ids":["s19"],"source_status":"sourced","why_material":"Supports mechanistic discussion of anxiolytic action.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Postherpetic neuralgia involves persistent nerve pain after shingles that can trigger secondary anxiety and stress responses.","section":"What's breaking down","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Frames the neurochemistry layer relevant to Selank.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"medical","url":"https://my.clevelandclinic.org/health/diseases/12093-postherpetic-neuralgia","title":"Postherpetic Neuralgia: What It Is, Symptoms & Treatment","quote":"Postherpetic neuralgia (PHN) is a complication of a shingles infection that causes persistent pain where you had a rash and blisters.","summary":"Overview of PHN as post-shingles nerve pain complication.","claim_ids":["c4","c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"3f9126b76d40bccf140ea66ff9d2dbdd929649375c6de15e2ac7f7e3f49bdaf6"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.","summary":"2008 Russian trial comparing Selank to medazepam in 62 patients.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"ok","quote_status":"verified","prev":"3f9126b76d40bccf140ea66ff9d2dbdd929649375c6de15e2ac7f7e3f49bdaf6","hash":"6f56a558ce185c4a4ad59576a44ae01166a7e33f46ce6d0972e2ade50392d3bf"},{"id":"s15","type":"other","url":"https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank...","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"Detailed abstract of the 2008 trial results.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"http_403","quote_status":"unverified","prev":"6f56a558ce185c4a4ad59576a44ae01166a7e33f46ce6d0972e2ade50392d3bf","hash":"9c4516500bcab6a2cc792a4090506e27b00c7502078da16a9638ea7b56a361a5"},{"id":"s19","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"Our results showed that Selank caused a number of alterations in the expression of genes involved in neurotransmission.","summary":"Rat study on gene expression changes after Selank.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"ok","quote_status":"verified","prev":"9c4516500bcab6a2cc792a4090506e27b00c7502078da16a9638ea7b56a361a5","hash":"cdb6dc3d970e1e4607e627db303a86b1cf9cc8a9f45e1bac82b9c343b0ac2c02"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:37:53.904Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers","register":"source_ledger","body":"## What's breaking down\n\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months or years in some people. Chronic pain often triggers secondary layers: elevated stress chemistry, disrupted sleep, and heightened anxiety that amplifies perceived pain intensity. If anxiety and non-restorative arousal form part of your experience, that neurochemistry layer becomes a separate target for repair pathways.\n\n## Why Selank might help you\n\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. In postherpetic neuralgia the constant pain input keeps the nervous system on high alert.\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\n3. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nRussian human trials examined Selank in generalized anxiety disorder and neurasthenia. Patients showed reductions in anxiety scores comparable to certain benzodiazepines yet without sedation or cognitive dulling. If your postherpetic pain feeds ongoing worry or tension that prevents rest, the studied effect on GABA-related gene expression and enkephalin stability offers a distinct angle focused on restoring balance rather than suppressing symptoms.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- Selank → anxiety / neurochemistry\n\nSelank addresses the neurochemical amplification layer that often accompanies chronic nerve pain. Other compounds would map to separate degeneration points such as direct nerve repair or inflammation if included.\n\n## What the evidence actually shows\n\nHuman data exists only for anxiety indications. One 2008 trial with 62 patients compared Selank to medazepam and reported similar anxiolytic effects plus additional anti-asthenic benefits. Another 2015 study of 70 patients noted improved outcomes when Selank was added to benzodiazepines with fewer side effects. These trials used psychometric scales such as Hamilton Anxiety Rating. No published human trials test Selank specifically in postherpetic neuralgia. Animal and in-vitro work shows changes in GABA receptor gene expression and inflammation-related genes, yet these remain preclinical. Anecdotal reports on forums describe subjective calm without sedation, but these lack controlled measurement.\n\n## What scientists say\n\nPublished papers describe Selank as producing anxiolytic activity comparable to classical benzodiazepines via possible allosteric modulation of GABA systems and effects on enkephalin degradation. Russian researchers note rapid or gradual response patterns in generalized anxiety disorder cohorts. Western reviews highlight small sample sizes and limited long-term data. No statements link the peptide directly to neuropathic pain syndromes such as postherpetic neuralgia.\n\n## What people say on Reddit\n\nDiscussions mention Selank in contexts of general anxiety or benzo tapering. Users report reduced mental tension and clearer thinking. No threads specifically tie Selank to postherpetic neuralgia pain scores. Reports remain subjective and unverified.\n\n## What people say on X\n\nPosts describe Selank as providing calm without fog. Some users note improved focus during stress. No verified posts reference postherpetic neuralgia or shingles-related pain.\n\n## What we do not know\n\nDirect effects on nerve pain pathways in postherpetic neuralgia remain unstudied in humans. Long-term safety beyond short Russian trials is unknown. Optimal use alongside standard neuropathic pain treatments lacks comparative data. Individual response variability and duration of benefit are not quantified outside anxiety populations.\n\n## Safety and limits\n\nReported side effects in available human studies appear minimal. Russian approval exists for generalized anxiety disorder. The compound is not FDA-evaluated or approved for any use in the United States. Evidence for any postherpetic application rests entirely on mechanistic overlap with anxiety pathways rather than condition-specific trials.","claims":[{"id":"c1","text":"No published human trials test Selank in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s0","s9"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2008 trial with 62 patients found Selank produced anxiolytic effects comparable to medazepam in generalized anxiety disorder and neurasthenia.","section":"What the evidence actually shows","tier":"human","source_ids":["s9","s15"],"source_status":"sourced","why_material":"Provides the primary human efficacy data for the peptide's studied indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Selank alters expression of genes involved in neurotransmission including GABA-related pathways in rat frontal cortex studies.","section":"What scientists say","tier":"preclinical","source_ids":["s19"],"source_status":"sourced","why_material":"Supports mechanistic discussion of anxiolytic action.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Postherpetic neuralgia involves persistent nerve pain after shingles that can trigger secondary anxiety and stress responses.","section":"What's breaking down","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Frames the neurochemistry layer relevant to Selank.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"medical","url":"https://my.clevelandclinic.org/health/diseases/12093-postherpetic-neuralgia","title":"Postherpetic Neuralgia: What It Is, Symptoms & Treatment","quote":"Postherpetic neuralgia (PHN) is a complication of a shingles infection that causes persistent pain where you had a rash and blisters.","link_status":"ok","quote_status":"verified"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.","link_status":"ok","quote_status":"verified"},{"id":"s15","type":"other","url":"https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank...","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","link_status":"http_403","quote_status":"unverified"},{"id":"s19","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"Our results showed that Selank caused a number of alterations in the expression of genes involved in neurotransmission.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":15147,"tokens_out":2547,"cost":0.02530125,"prev_hash":"genesis","hash":"f97259fbd9d78795bdabc52ebde85425aec974bb319bfa1e654d43242e808e22"}],"provenance":[{"ts":"2026-06-30T00:37:53.904Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Postherpetic\nSlug: selank-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the ","response":"{\n  \"slug\": \"selank-postherpetic\",\n  \"title\": \"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months or years in some people. Chronic pain often triggers secondary layers: elevated stress chemistry, disrupted sleep, and heightened anxiety that amplifies perceived pain intensity. If anxiety and non-restorative arousal form part of your experience, that neurochemistry layer becomes a separate target for repair pathways.\\n\\n## Why Selank might help you\\n\\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. In postherpetic neuralgia the constant pain input keeps the nervous system on high alert.\\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\\n\\nRussian human trials examined Selank in generalized anxiety disorder and neurasthenia. Patients showed reductions in anxiety scores comparable to certain benzodiazepines yet without sedation or cognitive dulling. If your postherpetic pain feeds ongoing worry or tension that prevents rest, the studied effect on GABA-related gene expression and enkephalin stability offers a distinct angle focused on restoring balance rather than suppressing symptoms.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- Selank → anxiety / neurochemistry\\n\\nSelank addresses the neurochemical amplification layer that often accompanies chronic nerve pain. Other compounds would map to separate ","tokens_in":15147,"tokens_out":2547,"cost":0,"prev":"genesis","hash":"dc8ed1b2b0e3f86b6f2ccdb97f3783c39b01a03c35e3544cc27671d4d4c30ec0"},{"ts":"2026-07-17T02:41:40.377Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-postherpetic","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"dc8ed1b2b0e3f86b6f2ccdb97f3783c39b01a03c35e3544cc27671d4d4c30ec0","hash":"71fdb9530f45f7873fcda03bd8b333990733892080c83186ead89caa03bc0a8f"}],"energy":{"passes":2,"tokens_in":15147,"tokens_out":2547,"tokens_total":17694,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"71fdb9530f45f7873fcda03bd8b333990733892080c83186ead89caa03bc0a8f"},"posted_at":"2026-06-29T21:33:06.682Z","created_at":"2026-06-29T21:33:06.682Z","updated_at":"2026-07-17T02:41:40.377Z","machine":{"shape":"article.machine/v1","slug":"selank-postherpetic","kind":"article","read":{"human":"https://miscsubjects.com/a/selank-postherpetic","json":"https://miscsubjects.com/api/articles/selank-postherpetic","bundle":"https://miscsubjects.com/api/articles/selank-postherpetic/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/selank-postherpetic/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=selank-postherpetic","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-postherpetic\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-postherpetic\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/selank-postherpetic/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"selank-postherpetic\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/selank-postherpetic | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/selank-postherpetic","json":"/api/articles/selank-postherpetic","markdown":"/api/articles/selank-postherpetic/bundle?format=markdown","skill":"/api/articles/selank-postherpetic/skill","topology":"/api/articles/selank-postherpetic/topology","versions":"/api/articles/selank-postherpetic/revisions","invocations":"/api/articles/selank-postherpetic/invocations"},"editorial_review":null,"editorial_audit":{"slug":"selank-postherpetic","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"32a716455c1fd3d6064d9be30ab94b146c8305eb602c733095a1dafd1ab36715","object":{"object_type":"article-object","identity":{"id":"article:selank-postherpetic","slug":"selank-postherpetic","title":"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/selank-postherpetic","role":"explain","audience":"human"},"skill":{"route":"/api/articles/selank-postherpetic/skill","role":"direct behavior","audience":"model","content":"---\nname: selank-postherpetic\ndescription: Apply the Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers\n\nThis Skill is the behavioral expression of [the canonical article](/a/selank-postherpetic). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/selank-postherpetic.\n- Read claims and relationships at /api/articles/selank-postherpetic/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Postherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months o\n\n## Representations\n\n- Human: /a/selank-postherpetic\n- JSON: /api/articles/selank-postherpetic\n- Relationships: /api/articles/selank-postherpetic/topology\n- History: /api/articles/selank-postherpetic/revisions\n"},"json":{"route":"/api/articles/selank-postherpetic","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/selank-postherpetic/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","selank","postherpetic"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/selank-postherpetic/invocations?status=success","failure_events":"/api/articles/selank-postherpetic/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"selank-postherpetic","title":"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers","body":"## What's breaking down\n\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months or years in some people. Chronic pain often triggers secondary layers: elevated stress chemistry, disrupted sleep, and heightened anxiety that amplifies perceived pain intensity. If anxiety and non-restorative arousal form part of your experience, that neurochemistry layer becomes a separate target for repair pathways.\n\n## Why Selank might help you\n\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. In postherpetic neuralgia the constant pain input keeps the nervous system on high alert.\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\n3. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nRussian human trials examined Selank in generalized anxiety disorder and neurasthenia. Patients showed reductions in anxiety scores comparable to certain benzodiazepines yet without sedation or cognitive dulling. If your postherpetic pain feeds ongoing worry or tension that prevents rest, the studied effect on GABA-related gene expression and enkephalin stability offers a distinct angle focused on restoring balance rather than suppressing symptoms.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- Selank → anxiety / neurochemistry\n\nSelank addresses the neurochemical amplification layer that often accompanies chronic nerve pain. Other compounds would map to separate degeneration points such as direct nerve repair or inflammation if included.\n\n## What the evidence actually shows\n\nHuman data exists only for anxiety indications. One 2008 trial with 62 patients compared Selank to medazepam and reported similar anxiolytic effects plus additional anti-asthenic benefits. Another 2015 study of 70 patients noted improved outcomes when Selank was added to benzodiazepines with fewer side effects. These trials used psychometric scales such as Hamilton Anxiety Rating. No published human trials test Selank specifically in postherpetic neuralgia. Animal and in-vitro work shows changes in GABA receptor gene expression and inflammation-related genes, yet these remain preclinical. Anecdotal reports on forums describe subjective calm without sedation, but these lack controlled measurement.\n\n## What scientists say\n\nPublished papers describe Selank as producing anxiolytic activity comparable to classical benzodiazepines via possible allosteric modulation of GABA systems and effects on enkephalin degradation. Russian researchers note rapid or gradual response patterns in generalized anxiety disorder cohorts. Western reviews highlight small sample sizes and limited long-term data. No statements link the peptide directly to neuropathic pain syndromes such as postherpetic neuralgia.\n\n## What people say on Reddit\n\nDiscussions mention Selank in contexts of general anxiety or benzo tapering. Users report reduced mental tension and clearer thinking. No threads specifically tie Selank to postherpetic neuralgia pain scores. Reports remain subjective and unverified.\n\n## What people say on X\n\nPosts describe Selank as providing calm without fog. Some users note improved focus during stress. No verified posts reference postherpetic neuralgia or shingles-related pain.\n\n## What we do not know\n\nDirect effects on nerve pain pathways in postherpetic neuralgia remain unstudied in humans. Long-term safety beyond short Russian trials is unknown. Optimal use alongside standard neuropathic pain treatments lacks comparative data. Individual response variability and duration of benefit are not quantified outside anxiety populations.\n\n## Safety and limits\n\nReported side effects in available human studies appear minimal. Russian approval exists for generalized anxiety disorder. The compound is not FDA-evaluated or approved for any use in the United States. Evidence for any postherpetic application rests entirely on mechanistic overlap with anxiety pathways rather than condition-specific trials.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/selank-postherpetic/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No published human trials test Selank in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s0","s9"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2008 trial with 62 patients found Selank produced anxiolytic effects comparable to medazepam in generalized anxiety disorder and neurasthenia.","section":"What the evidence actually shows","tier":"human","source_ids":["s9","s15"],"source_status":"sourced","why_material":"Provides the primary human efficacy data for the peptide's studied indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Selank alters expression of genes involved in neurotransmission including GABA-related pathways in rat frontal cortex studies.","section":"What scientists say","tier":"preclinical","source_ids":["s19"],"source_status":"sourced","why_material":"Supports mechanistic discussion of anxiolytic action.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Postherpetic neuralgia involves persistent nerve pain after shingles that can trigger secondary anxiety and stress responses.","section":"What's breaking down","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Frames the neurochemistry layer relevant to Selank.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"medical","url":"https://my.clevelandclinic.org/health/diseases/12093-postherpetic-neuralgia","title":"Postherpetic Neuralgia: What It Is, Symptoms & Treatment","quote":"Postherpetic neuralgia (PHN) is a complication of a shingles infection that causes persistent pain where you had a rash and blisters.","summary":"Overview of PHN as post-shingles nerve pain complication.","claim_ids":["c4","c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"3f9126b76d40bccf140ea66ff9d2dbdd929649375c6de15e2ac7f7e3f49bdaf6"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.","summary":"2008 Russian trial comparing Selank to medazepam in 62 patients.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"ok","quote_status":"verified","prev":"3f9126b76d40bccf140ea66ff9d2dbdd929649375c6de15e2ac7f7e3f49bdaf6","hash":"6f56a558ce185c4a4ad59576a44ae01166a7e33f46ce6d0972e2ade50392d3bf"},{"id":"s15","type":"other","url":"https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank...","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"Detailed abstract of the 2008 trial results.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"http_403","quote_status":"unverified","prev":"6f56a558ce185c4a4ad59576a44ae01166a7e33f46ce6d0972e2ade50392d3bf","hash":"9c4516500bcab6a2cc792a4090506e27b00c7502078da16a9638ea7b56a361a5"},{"id":"s19","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"Our results showed that Selank caused a number of alterations in the expression of genes involved in neurotransmission.","summary":"Rat study on gene expression changes after Selank.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:37:52.917Z","link_status":"ok","quote_status":"verified","prev":"9c4516500bcab6a2cc792a4090506e27b00c7502078da16a9638ea7b56a361a5","hash":"cdb6dc3d970e1e4607e627db303a86b1cf9cc8a9f45e1bac82b9c343b0ac2c02"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:37:53.904Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers","register":"source_ledger","body":"## What's breaking down\n\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months or years in some people. Chronic pain often triggers secondary layers: elevated stress chemistry, disrupted sleep, and heightened anxiety that amplifies perceived pain intensity. If anxiety and non-restorative arousal form part of your experience, that neurochemistry layer becomes a separate target for repair pathways.\n\n## Why Selank might help you\n\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. In postherpetic neuralgia the constant pain input keeps the nervous system on high alert.\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\n3. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\nRussian human trials examined Selank in generalized anxiety disorder and neurasthenia. Patients showed reductions in anxiety scores comparable to certain benzodiazepines yet without sedation or cognitive dulling. If your postherpetic pain feeds ongoing worry or tension that prevents rest, the studied effect on GABA-related gene expression and enkephalin stability offers a distinct angle focused on restoring balance rather than suppressing symptoms.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- Selank → anxiety / neurochemistry\n\nSelank addresses the neurochemical amplification layer that often accompanies chronic nerve pain. Other compounds would map to separate degeneration points such as direct nerve repair or inflammation if included.\n\n## What the evidence actually shows\n\nHuman data exists only for anxiety indications. One 2008 trial with 62 patients compared Selank to medazepam and reported similar anxiolytic effects plus additional anti-asthenic benefits. Another 2015 study of 70 patients noted improved outcomes when Selank was added to benzodiazepines with fewer side effects. These trials used psychometric scales such as Hamilton Anxiety Rating. No published human trials test Selank specifically in postherpetic neuralgia. Animal and in-vitro work shows changes in GABA receptor gene expression and inflammation-related genes, yet these remain preclinical. Anecdotal reports on forums describe subjective calm without sedation, but these lack controlled measurement.\n\n## What scientists say\n\nPublished papers describe Selank as producing anxiolytic activity comparable to classical benzodiazepines via possible allosteric modulation of GABA systems and effects on enkephalin degradation. Russian researchers note rapid or gradual response patterns in generalized anxiety disorder cohorts. Western reviews highlight small sample sizes and limited long-term data. No statements link the peptide directly to neuropathic pain syndromes such as postherpetic neuralgia.\n\n## What people say on Reddit\n\nDiscussions mention Selank in contexts of general anxiety or benzo tapering. Users report reduced mental tension and clearer thinking. No threads specifically tie Selank to postherpetic neuralgia pain scores. Reports remain subjective and unverified.\n\n## What people say on X\n\nPosts describe Selank as providing calm without fog. Some users note improved focus during stress. No verified posts reference postherpetic neuralgia or shingles-related pain.\n\n## What we do not know\n\nDirect effects on nerve pain pathways in postherpetic neuralgia remain unstudied in humans. Long-term safety beyond short Russian trials is unknown. Optimal use alongside standard neuropathic pain treatments lacks comparative data. Individual response variability and duration of benefit are not quantified outside anxiety populations.\n\n## Safety and limits\n\nReported side effects in available human studies appear minimal. Russian approval exists for generalized anxiety disorder. The compound is not FDA-evaluated or approved for any use in the United States. Evidence for any postherpetic application rests entirely on mechanistic overlap with anxiety pathways rather than condition-specific trials.","claims":[{"id":"c1","text":"No published human trials test Selank in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s0","s9"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the target condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2008 trial with 62 patients found Selank produced anxiolytic effects comparable to medazepam in generalized anxiety disorder and neurasthenia.","section":"What the evidence actually shows","tier":"human","source_ids":["s9","s15"],"source_status":"sourced","why_material":"Provides the primary human efficacy data for the peptide's studied indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Selank alters expression of genes involved in neurotransmission including GABA-related pathways in rat frontal cortex studies.","section":"What scientists say","tier":"preclinical","source_ids":["s19"],"source_status":"sourced","why_material":"Supports mechanistic discussion of anxiolytic action.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Postherpetic neuralgia involves persistent nerve pain after shingles that can trigger secondary anxiety and stress responses.","section":"What's breaking down","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Frames the neurochemistry layer relevant to Selank.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:37:53.300Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"medical","url":"https://my.clevelandclinic.org/health/diseases/12093-postherpetic-neuralgia","title":"Postherpetic Neuralgia: What It Is, Symptoms & Treatment","quote":"Postherpetic neuralgia (PHN) is a complication of a shingles infection that causes persistent pain where you had a rash and blisters.","link_status":"ok","quote_status":"verified"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.","link_status":"ok","quote_status":"verified"},{"id":"s15","type":"other","url":"https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank...","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients).","link_status":"http_403","quote_status":"unverified"},{"id":"s19","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in Neurotransmission","quote":"Our results showed that Selank caused a number of alterations in the expression of genes involved in neurotransmission.","link_status":"ok","quote_status":"verified"}]},"rationale":"","tokens_in":15147,"tokens_out":2547,"cost":0.02530125,"prev_hash":"genesis","hash":"f97259fbd9d78795bdabc52ebde85425aec974bb319bfa1e654d43242e808e22"}],"provenance":[{"ts":"2026-06-30T00:37:53.904Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Postherpetic\nSlug: selank-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the ","response":"{\n  \"slug\": \"selank-postherpetic\",\n  \"title\": \"Selank for Postherpetic Neuralgia: Anxiety and Neurochemistry Evidence Layers\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages nerve fibers. The rash heals but pain signals continue firing. This creates burning, stabbing, or sensitive skin that lasts months or years in some people. Chronic pain often triggers secondary layers: elevated stress chemistry, disrupted sleep, and heightened anxiety that amplifies perceived pain intensity. If anxiety and non-restorative arousal form part of your experience, that neurochemistry layer becomes a separate target for repair pathways.\\n\\n## Why Selank might help you\\n\\n1. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal. In postherpetic neuralgia the constant pain input keeps the nervous system on high alert.\\n2. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\\n\\nRussian human trials examined Selank in generalized anxiety disorder and neurasthenia. Patients showed reductions in anxiety scores comparable to certain benzodiazepines yet without sedation or cognitive dulling. If your postherpetic pain feeds ongoing worry or tension that prevents rest, the studied effect on GABA-related gene expression and enkephalin stability offers a distinct angle focused on restoring balance rather than suppressing symptoms.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- Selank → anxiety / neurochemistry\\n\\nSelank addresses the neurochemical amplification layer that often accompanies chronic nerve pain. Other compounds would map to separate ","tokens_in":15147,"tokens_out":2547,"cost":0,"prev":"genesis","hash":"dc8ed1b2b0e3f86b6f2ccdb97f3783c39b01a03c35e3544cc27671d4d4c30ec0"},{"ts":"2026-07-17T02:41:40.377Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-postherpetic","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"dc8ed1b2b0e3f86b6f2ccdb97f3783c39b01a03c35e3544cc27671d4d4c30ec0","hash":"71fdb9530f45f7873fcda03bd8b333990733892080c83186ead89caa03bc0a8f"}],"energy":{"passes":2,"tokens_in":15147,"tokens_out":2547,"tokens_total":17694,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"71fdb9530f45f7873fcda03bd8b333990733892080c83186ead89caa03bc0a8f"},"posted_at":"2026-06-29T21:33:06.682Z","created_at":"2026-06-29T21:33:06.682Z","updated_at":"2026-07-17T02:41:40.377Z","machine":{"shape":"article.machine/v1","slug":"selank-postherpetic","kind":"article","read":{"human":"https://miscsubjects.com/a/selank-postherpetic","json":"https://miscsubjects.com/api/articles/selank-postherpetic","bundle":"https://miscsubjects.com/api/articles/selank-postherpetic/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/selank-postherpetic/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=selank-postherpetic","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-postherpetic\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"selank-postherpetic\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/selank-postherpetic/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"selank-postherpetic\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/selank-postherpetic | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/selank-postherpetic","json":"/api/articles/selank-postherpetic","markdown":"/api/articles/selank-postherpetic/bundle?format=markdown","skill":"/api/articles/selank-postherpetic/skill","topology":"/api/articles/selank-postherpetic/topology","versions":"/api/articles/selank-postherpetic/revisions","invocations":"/api/articles/selank-postherpetic/invocations"},"editorial_review":null,"editorial_audit":{"slug":"selank-postherpetic","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"32a716455c1fd3d6064d9be30ab94b146c8305eb602c733095a1dafd1ab36715"}}}